0001179110-20-001133.txt : 20200205 0001179110-20-001133.hdr.sgml : 20200205 20200205160205 ACCESSION NUMBER: 0001179110-20-001133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200203 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levy Lewis CENTRAL INDEX KEY: 0001726568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20578718 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-02-03 0 0001477449 Teladoc Health, Inc. TDOC 0001726568 Levy Lewis C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Medical Officer Common Stock 2020-02-03 4 M 0 1275 35.45 A 5655 D Common Stock 2020-02-03 4 M 0 750 38.55 A 6405 D Common Stock 2020-02-03 4 S 0 2025 102.69 D 4380 D Employee Stock Option (right to buy) 35.45 2020-02-03 4 M 0 1275 0.00 D 2027-07-14 Common Stock 1275 23228 D Employee Stock Option (right to buy) 38.55 2020-02-03 4 M 0 750 0.00 D 2028-03-01 Common Stock 750 34750 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort, attorney-in-fact 2020-02-05